Whittier Trust’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$143 Hold
69
﹤0.01% 1336
2025
Q4
$200 Hold
69
﹤0.01% 1345
2025
Q3
$313 Hold
69
﹤0.01% 1363
2025
Q2
$343 Sell
69
-69
-50% -$300 ﹤0.01% 1484
2025
Q1
$608 Hold
138
﹤0.01% 1453
2024
Q4
$640 Hold
138
﹤0.01% 1509
2024
Q3
$956 Hold
138
﹤0.01% 1496
2024
Q2
$1.08K Hold
138
﹤0.01% 1463
2024
Q1
$978 Hold
138
﹤0.01% 1455
2023
Q4
$924 Sell
138
-308
-69% -$1.73K ﹤0.01% 1448
2023
Q3
$2.51K Sell
446
-2
-0.4% -$13 ﹤0.01% 1443
2023
Q2
$2.47K Sell
448
-11,148
-96% -$60K ﹤0.01% 1434
2023
Q1
$72.5K Hold
11,596
﹤0.01% 892
2022
Q4
$54K Sell
11,596
-1,039
-8% -$5.12K ﹤0.01% 948
2022
Q3
$59K Hold
12,635
﹤0.01% 941
2022
Q2
$75K Buy
+12,635
New +$141K ﹤0.01% 871

Other funds holding GDRX

Whittier Trust's GDRX Position: Q1 2026 in Review

Whittier Trust held its GoodRx Holdings (GDRX) position steady in Q1 2026 at 69 shares worth $143. The position accounts for ﹤0.01% of the portfolio, ranked #1336.

Whittier Trust first reported a position in GDRX in Q2 2022 and has held it in 16 quarters since. The position peaked at $75K in Q2 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Whittier Trust held 69 shares of GoodRx Holdings worth $143 as of Q1 2026.
  • Whittier Trust left its GoodRx Holdings share count unchanged in Q1 2026.
  • GoodRx Holdings made up ﹤0.01% of Whittier Trust's portfolio in Q1 2026, its #1336 holding.
  • Whittier Trust first reported a position in GoodRx Holdings in Q2 2022 and has held it in 16 quarters since.
  • Whittier Trust's GoodRx Holdings position peaked at $75K in Q2 2022.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.